To confirm CB11-mediated cell cycle arrest in NSCLC cells, a Western blot analysis was performed, and the data indicate that CB11 induced dose-dependent phosphorylation of ATR, chk2, and p53 and increased GADD45α levels (Fig. 3b). Here, CHEK2 is linked to non-small cell lung carcinoma.